Israel Englander Immunovant, Inc. Call Options Transaction History

Millennium Management LLC

  • $224 Billion
  • Q1 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 15, 2024
BUY
$30.27 - $43.79 $12,108 - $17,516
400 Added 0.37%
109,200 $3.53 Million
Q4 2023

Feb 14, 2024
BUY
$31.31 - $44.19 $3.41 Million - $4.81 Million
108,800 New
108,800 $4.58 Million
Q3 2022

Nov 14, 2022
BUY
$3.93 - $6.37 $393,000 - $637,000
100,000 New
100,000 $558,000

Others Institutions Holding IMVT

# of Institutions
238
Shares Held
62.9M
Call Options Held
1.46M
Put Options Held
546K
View Full List

About Immunovant, Inc.

IMVT Quotes by TradingView
  • Ticker IMVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 129,077,000
  • Market Cap $3.55B
  • Description
  • Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...
More about IMVT
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email